alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 6913]

Pursuant to the authority vested in me as Secretary of State, including by Presidential Delegation No. 2007-29 of August 27, 2007, I hereby determine that it is in the national security interests of the United States to make available $200,000,000 appropriated under the heading Economic Support Funds in the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2009 (Div. H, Pub. L. 111-8), without regard to the restriction in the sixth proviso under that heading.

                    This determination shall be reported to the Congress promptly and published in the                     **Federal Register**                    .                

Dated: October 15, 2009.

Hillary Rodham Clinton,

 Secretary of State.

[FR Doc. 2010-4604 Filed 3-3-10; 8:45 am]

BILLING CODE 4710-17-P
EXHIBIT 32



SECTION 1350 CERTIFICATION OF SIDNEY CAMPER III AND RICHARD DEA



SECTION 1350 CERTIFICATION



In connection with the quarterly report of InZon Corporation (Company) on Form 10-QSB for the quarter ended December 31, 2007 as filed with the Securities and Exchange Commission (Report), the undersigned, in the capacities and on the dated indicated below, hereby certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2003 (18 U.S.C. Section 1350) that to their knowledge:



1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                         |  |     |                         | 
|------------------------ |  | --- | ----------------------- | 
|                         |  |     |                         | 
|Dated: February 19, 2008 |  | By: | /s/ Sidney Camper III   | 
|                         |  |     | Sidney Camper III       | 
|                         |  |     | Chief Executive Officer | 
|                         |  |     |                         | 
|Dated: February 19, 2008 |  | By: | /s/ Richard Dea         | 
|                         |  |     | Richard Dea             | 
|                         |  |     | Chief Financial Officer |
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

February 19, 2008 Clifford W. Taylor,
Chief Justice

Michael F. Cavanagh
Elizabeth A. Weaver 135330 Marilyn Kelly Maura D. Corrigan Robert P. Young, Jr. Stephen J. Markman, MARGARET MANETTA, as Personal Justices Representative of the Estate of ROBERT MANETTA, Deceased, Plaintiff-Appellee,

v SC: 135330 COA: 265988 Macomb CC: 2001-001272-NH JAMES E. JOHNSON, D.O., and MACOMB SURGICAL ASSOCIATES, Defendants-Appellants,

and

MT. CLEMENS GENERAL HOSPITAL INCORPORATED, Defendant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the October 30, 2007 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

d0211 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

February 19, 2008

Clerk
State of Washington

40 CFR 52

– Subpart WW

Materials Incorporated by Reference

40 CFR 52.2470 (c ) and (d)

February 19, 2016

US EPA Region 10

Office of Air, Waste, and Toxics

1200 Sixth Avenue

Seattle, WA 98101
Editorial Note on Part 888
Editorial Note: Nomenclature changes to part 888 appear at 73 FR 35341, June 23, 2008.

§ 888.3180 Elbow joint humeral (hemi-elbow) metallic uncemented prosthesis. ( a ) *Identification.* An elbow joint humeral (hemi-elbow) metallic uncemented prosthesis is a device intended to be implanted made of alloys, such as cobalt-chromium-molybdenum, that is used to replace the distal end of the humerus formed by the trochlea humeri and the capitulum humeri. The generic type of device is limited to prostheses intended for use without bone cement (§ 888.3027).
( b ) *Classification.* Class III.
( c ) *Date PMA or notice of completion of a PDP is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any elbow joint humeral (hemi-elbow) metallic uncemented prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to an elbow joint humeral (hemi-elbow) metallic uncemented prosthesis that was in commercial distribution before May 28, 1976. Any other elbow joint humeral (hemi-elbow) metallic uncemented prosthesis shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[52 FR 33702, Sept. 4, 1987, as amended at 61 FR 50709, Sept. 27, 1996]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Judicial Conference of the United States

# AGENCY:

Judicial Conference of the United States Advisory Committee on Rules of Appellate Procedure.

# ACTION:

Notice of open meeting.

# SUMMARY:

The Advisory Committee on Rules of Appellate Procedure will hold a two-day meeting. The meeting will be open to public observation but not participation.

# DATES:

April 8-9, 2010.

# TIME:

8:30 a.m. to 5 p.m.

# ADDRESSES:

Inn on Biltmore Estate, I Approach Road, Asheville, NC 28803.

# FOR FURTHER INFORMATION CONTACT:

John K. Rabiej, Chief, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502-1820.

Dated: March 4, 2010.

John K. Rabiej,

Chief, Rules Committee Support Office.

[FR Doc. 2010-5072 Filed 3-10-10; 8:45 am]

BILLING CODE 2210-55-M
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

# AGENCY HOLDING THE MEETING:

Board of Governors of the Federal Reserve System.

# TIME AND DATE:

12 p.m., Monday, March 15, 2010.

# PLACE:

Marriner S. Eccles Federal Reserve Board Building, 20th and C Streets, N.W., Washington, D.C. 20551.

# STATUS:

Closed.

# MATTERS TO BE CONSIDERED: 

1. Personnel actions (appointments, promotions, assignments, reassignments, and salary actions) involving individual Federal Reserve System employees.

2. Any items carried forward from a previously announced meeting.

# FOR FURTHER INFORMATION CONTACT:

Michelle Smith, Director, or Dave Skidmore, Assistant to the Board, Office of Board Members at 202-452-2955.

# SUPPLEMENTARY INFORMATION:

                        You may call 202-452-3206 beginning at approximately 5 p.m. two business days before the meeting for a recorded announcement of bank and bank holding company applications scheduled for the meeting; or you may contact the Board's Web site at                         *http://www.federalreserve.gov*                         for an electronic announcement that not only lists applications, but also indicates procedural and other information about the meeting.                    

Board of Governors of the Federal Reserve System, March 5, 2010.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 2010-5106 Filed 3-5-10; 4:15 pm]

BILLING CODE 6210-01-S
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.4630 Dental operating light. ( a ) *Identification.* A dental operating light, including the surgical headlight, is an AC-powered device intended to illuminate oral structures and operating areas.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9.
[52 FR 30097, Aug. 12, 1987, as amended at 61 FR 1121, Jan. 16, 1996; 66 FR 38799, July 25, 2001]
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED FEBRUARY 5, 2014

NO. 03-13-00153-CV

Anurekha Chadha, M.D. and Austin Regional Clinic, P.A., Appellants

v.

Sharon Rothert and Fred Rothert, Appellees

APPEAL FROM 201ST DISTRICT COURT OF TRAVIS COUNTY

BEFORE JUSTICES PURYEAR, ROSE AND GOODWIN

AFFIRMED -- OPINION BY JUSTICE PURYEAR

This is an appeal from the interlocutory order entered by the trial court on February 11, 2013. 

Having reviewed the record and the parties’ arguments, the Court holds that there was no 

reversible error in the trial court’s interlocutory order. Therefore, the Court affirms the trial 

court’s interlocutory order. The appellants shall pay all costs relating to this appeal, both in this 

Court and the court below.
# C_2014078EN.01001401.xml

| 15.3.2014 | EN | Official Journal of the European Union | C 78/14 |
| --- | --- | --- | --- |

15.3.2014

EN

Official Journal of the European Union

C 78/14

---

Action brought on 14 January 2014 — José Manuel Baena Grupo v OHIM — Neuman and Galdeano del Sel (Representation of a seated figure)

(Case T-28/14)

2014/C 78/28

Language in which the application was lodged: Spanish

Parties

Parties

Applicant: José Manuel Baena Grupo, SA (Santa Perpètua de Mogoda, Spain) (represented by: A. Canela Giménez, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Herbert Neuman and Andoni Galdeano del Sel (Tarifa, Spain)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul OHIM’s decision; |
| --- | --- |

—

annul OHIM’s decision;

| — | order OHIM to pay the costs. |
| --- | --- |

—

order OHIM to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

Registered Community trade mark in respect of which a declaration of invalidity has been sought: Registered Community design No 426 895-002 for ‘T-shirts (Ornamentation for); Caps (Ornamentation for); Stickers (Ornamentation for); Printed matter, including advertising materials (Ornamentation for)’.

Registered Community trade mark in respect of which a declaration of invalidity has been sought:

Proprietor of the Community trade mark: Applicant

Proprietor of the Community trade mark:

Applicant for the declaration of invalidity of the Community trade mark: Herbert Neuman and Andoni Galdeano del Sel

Applicant for the declaration of invalidity of the Community trade mark:

Mark or design of the applicant for the declaration of invalidity: Community figurative mark No 1 312 651, for goods in Classes 25, 28, and 32 of the Nice Classification.

Mark or design of the applicant for the declaration of invalidity:

Decision of the Cancellation Division: Application upheld and design declared invalid

Decision of the Cancellation Division:

Decision of the Board of Appeal: Appeal dismissed in part

Decision of the Board of Appeal:

Pleas in law: Incorrect interpretation of Regulation No 6/2002

Pleas in law:

---
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief. ( a ) *Identification.* A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.
( b ) *Classification.* Class II (performance standards).
[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Page 10865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4889]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Open Meeting of the Area 3 Taxpayer Advocacy Panel (Including the 
States of Florida, Georgia, Alabama, Mississippi, Louisiana, Arkansas, 
and the Territory of Puerto Rico)

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: An open meeting of the Area 3 Taxpayer Advocacy Panel will be 
conducted. The Taxpayer Advocacy Panel is soliciting public comments, 
ideas, and suggestions on improving customer service at the Internal 
Revenue Service.

DATES: The meeting will be held Monday, April 12, 2010.

FOR FURTHER INFORMATION CONTACT: Donna Powers at 1-888-912-1227 or 954-
423-7977.

SUPPLEMENTARY INFORMATION: Notice is hereby given pursuant to Section 
10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) 
that a meeting of the Area 3 Taxpayer Advocacy Panel will be held 
Monday, April 12, 2010, at 2:30 p.m. Eastern Time via telephone 
conference. The public is invited to make oral comments or submit 
written statements for consideration. Due to limited conference lines, 
notification of intent to participate must be made with Donna Powers. 
For more information, please contact Ms. Powers at 1-888-912-1227 or 
954-423-7977, or write TAP Office, 1000 South Pine Island Road, Suite 
340, Plantation, FL 33324, or post comments to the Web site: http://www.improveirs.org.
    The agenda will include various IRS issues.

    Dated: March 3, 2010.
Shawn F. Collins,
Acting Director, Taxpayer Advocacy Panel.
[FR Doc. 2010-4889 Filed 3-8-10; 8:45 am]
BILLING CODE 4830-01-P
Exhibit 31.a

I, John P. Manning, certify that:

1. I have reviewed this quarterly report on Form 10-Q of American Affordable Housing II Limited Partnership;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



1. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and





1. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



1. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
2. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





|Date: February 23, 2007 | /s/ John P. Manning        
|----------------------- | ---------------------------
|                        | John P. Manning            
|                        | Principal Executive Officer
|                        |                            
|                        |                            
|                        |
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.1925 Toynbee diagnostic tube. ( a ) *Identification.* The toynbee diagnostic tube is a listening device intended to determine the degree of openness of the eustachian tube.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 874.9.
[51 FR 40389, Nov. 6, 1986, as amended at 65 FR 2316, Jan. 14, 2000]
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > The Relationship of Prices to Economic Stability and Growth

              																	United States. Congress. Joint Economic Committee, 1956-					 and 	Eighty-Fifth Congress, 1957-1959. 						*The Relationship of Prices to Economic Stability and Growth : Compendium of Papers Submitted by Panelists Appearing Before the Joint Economic Committee*,												Washington: 								Government Printing Office, 										March 31, 1958,									https://fraser.stlouisfed.org/title/101,			accessed on September 10, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1410 Iron (non-heme) test system. ( a ) *Identification.* An iron (non-heme) test system is a device intended to measure iron (non-heme) in serum and plasma. Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
[52 FR 16122, May 1, 1987, as amended at 84 FR 71796, Dec. 30, 2019]